Donanemab

(Synonyms: LY3002813)
Customer Review

Based on 1 Customer Validation

Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody directed at an N-terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research.

For research use only. We do not sell to patients.

  • Purity: 99.19%
  • CAS No.: 1931944-80-7
  • Molecular Weight:145.36 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00